FIBANTIVIN Trademark

Trademark Overview

On Friday, June 12, 2020, a trademark application was filed for FIBANTIVIN with the United States Patent and Trademark Office. The USPTO has given the FIBANTIVIN trademark a serial number of 88962050. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 27, 2023. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The FIBANTIVIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of musculoskeletal, bone, and connective tissue diseases and disorders
fibantivin

General Information

Serial Number88962050
Word MarkFIBANTIVIN
Filing DateFriday, June 12, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 1, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for treatment of musculoskeletal, bone, and connective tissue diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 10, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Monday, November 27, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 27, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, April 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 6, 2023SOU EXTENSION 5 GRANTED
Tuesday, March 28, 2023SOU EXTENSION 5 FILED
Thursday, April 6, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 28, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 26, 2022SOU EXTENSION 4 GRANTED
Monday, September 26, 2022SOU EXTENSION 4 FILED
Monday, September 26, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 17, 2022ASSIGNED TO EXAMINER
Friday, March 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 23, 2022SOU EXTENSION 3 GRANTED
Wednesday, March 23, 2022SOU EXTENSION 3 FILED
Wednesday, March 23, 2022SOU TEAS EXTENSION RECEIVED
Saturday, October 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 14, 2021SOU EXTENSION 2 GRANTED
Thursday, October 14, 2021SOU EXTENSION 2 FILED
Thursday, October 14, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, March 31, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 29, 2021SOU EXTENSION 1 GRANTED
Monday, March 29, 2021SOU EXTENSION 1 FILED
Monday, March 29, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, October 27, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 1, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 1, 2020PUBLISHED FOR OPPOSITION
Wednesday, August 12, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 24, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 23, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, July 23, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 23, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, July 23, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, July 23, 2020ASSIGNED TO EXAMINER
Friday, July 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 16, 2020NEW APPLICATION ENTERED

Related Keywords

fibantivin tissue diseases disorders connective bone preparations treatment musculoskeletal pharmaceutical